0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

UNTOWARD EFFECTS OF PHENYTOIN SODIUM IN EPILEPSY

ISIDORE FINKELMAN, M.D.; A. J. ARIEFF, M.D.
JAMA. 1942;118(14):1209-1212. doi:10.1001/jama.1942.02830140039012.
Text Size: A A A
Published online

Merritt and Putnam1 found that while phenytoin sodium (sodium diphenyl hydantoinate, or dilantin sodium) was effective in protecting animals from electrically induced convulsions it produced little sedative effect. The effectiveness of this drug was then determined by them2 in a group of 200 patients who had been having frequent convulsive seizures for many years and who had obtained little or no benefit from the usually accepted treatment. Certain toxic effects were observed, among them dermatitis, nonthrombopenic purpura, tremors, ataxia and dizziness.

Although Fetterman3 reported that phenytoin sodium had a high degree of therapeutic value, he observed disquieting side actions such as itching, a cutaneous rash, swelling of the gums, tremors and ataxia, blurring of vision, loss of taste and dysesthesia in the mouth, restlessness, insomnia, irritability, paranoid state, anorexia, gastric distress and loss of weight. A study of the table published by Fetterman shows that 23 of

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

113 Views
0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
×
brightcove.createExperiences();